Thyroid disorder decisions — 2025

The Board denied service connection for decreased memory due to the absence of a current disability, while remanding claims for non-alcoholic fatty liver with cirrhosis, hypothyroidism, hypertension, and obstructive sleep apnea (OSA) for further development.

The Board denied service connection for coronary artery disease, prostate cancer, and hypothyroidism prior to August 10, 2022.

The Board granted service connection for left ear hearing loss and denied service connection for right ear hearing loss. The appeal for entitlement to service connection for a disease of the thyroid, to include goiter and hypothyroidism, was remanded.

The Board granted service connection for hypothyroidism, resolving reasonable doubt in the Veteran's favor. The issues of entitlement to service connection for kidney disease and left ear hearing loss were remanded.

The Board remands the case to obtain an addendum opinion regarding the nature and etiology of hyperthyroidism, specifically addressing whether it is related to service exposure to herbicide agents.

The Board remands the claim for service connection for hyperthyroidism, to include Graves' Disease, for a medical opinion addressing the etiology of the condition.

The Board remands the claim for service connection for hyperthyroidism due to a pre-decisional duty to assist error in the January 2024 VA opinion.

The Board denied service connection for diabetes mellitus type II, hypertension, and hypothyroidism prior to August 10, 2022, but granted a 10 percent rating for painful scars of the bilateral knees.

The Board granted service connection for hypothyroidism on a presumptive basis and denied service connection for Parkinsonism due to the lack of evidence supporting a diagnosis.

The Board denied earlier effective dates for service connection and initial ratings for hypertension and hypothyroidism, granting a separate 10 percent rating for cold sensitivity due to hypothyroidism.

The Board denied the Veteran's claims for an initial compensable rating for hypothyroidism and service connection for a hip condition, as there was no evidence of myxedema or a diagnosis of a hip condition during the appeal period.

The Board restored the 100 percent rating for prostate cancer from August 1, 2022 to November 28, 2022 and denied a compensable rating for hypothyroidism. The effective date for TDIU was dismissed as moot.

The Board denied the veteran's claim for a compensable rating for his right thyroid Hurtle cell follicular neoplasm, status post right partial thyroidectomy, as there was no evidence of abnormal thyroid function.

The Board denied the veteran's claims for increased ratings and service connection, as well as remanded several issues for further development.

The Board remands the claim for an initial, compensable rating for residuals of a malignant neoplasm of the thyroid due to an inadequate disability benefits questionnaire.

The Board remands the claims for service connection for hypothyroidism and bilateral hearing loss due to a need for VA examinations.

The Board denied an initial compensable rating for the Veteran's service-connected hypothyroidism.

The Board denied the Veteran's claim for service connection for thyroid nodules, finding no evidence of a causal relationship between his condition and his military service. The claims for service connection for prostate cancer, asthma, and nose polyps were remanded for further development.

The Board granted a 10 percent rating for right ear hearing loss but denied compensable ratings for left ear hearing loss and hypothyroidism.

The Board granted service connection for a dental disability as secondary to hypoparathyroidism, but denied increased ratings for hypoparathyroidism, Bell's palsy, right hand cramping and numbness, and left hand cramping and numbness.